UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 24, 2013
Accession Number:
Submission Type:
CIK:
0001042074
Company Name:
CymaBay Therapeutics, Inc.
File Number:
333-192617